Based on recent data, Lexicon Pharmaceuticals, Inc. (LXRX) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 477.58M. Its average trading volume over the past 3 months is 3.11M, indicating liquidity. These fundamental metrics provide insight into LXRX's underlying financial health and market activity.
| ATR | 0.12 |
| Enterprise Value | 477.58M |
| Avg Vol (3 Months) | 3.11M |
| Avg Vol (10 Days) | 10.29M |
Lexicon Pharmaceuticals, Inc. (LXRX) technical indicators as of June 27, 2026: the SMA 20 is 11.4%, SMA 50 at 14.43%, and SMA 200 at 27.48%. The RSI 14 value is 57.73, suggesting its current momentum. These technical analysis signals help assess LXRX's price trends and potential future movements.
| SMA 20 | 11.4% |
| SMA 50 | 14.43% |
| SMA 200 | 27.48% |
| RSI 14 | 57.73 |
Lexicon Pharmaceuticals, Inc. (LXRX) stock performance overview as of June 27, 2026: The 52-week high is $2.55 (currently -18.03% below), and the 52-week low is $0.801 (currently 428.91% above). Over the past year, LXRX's performance is 83.63%, compared to the S&P 500's 7.55% change.
| 52-Week High | 2.55 |
| 52-Week High Chg | -18.03% |
| 52-Week Low | 0.8006 |
| 52-Week Low Chg | +428.91% |
| S&P 500 52-Week Chg | 7.55% |
According to market data, Lexicon Pharmaceuticals, Inc. (LXRX) stock's recent performance metrics show that over the last month, LXRX is 13.91%, with a Year-to-Date (YTD) performance of 13.91%. Over the past year, the stock has seen a 83.63% change. These figures summarize LXRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 |
| Low | 1.99 | 1.8 | 1.49 | 1.1 | 0.8006 | 1.1 |
| Performance | +11.02% | +13.91% | -7.75% | +6.50% | +83.63% | +13.91% |
According to current financial data, LXRX stock's P/E (TTM) ratio is -35.71, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.21. Key valuation ratios for LXRX, including P/S (16.26), P/B (5.03), and P/FCF (-29.19), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | LXRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -35.71 | -1.21 | -193.77 | 32.59 |
| P/S (TTM) | 16.26 | 3.68 | 466.48 | 5.98 |
| P/B (TTM) | 5.03 | 1 | 11.15 | 5.4 |
| P/FCF (TTM) | -29.19 | -13.31 | -975.27 | 30.58 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep